DOI: 10.1055/s-00040811

Neurologie up2date

References

Mathis MV, Muoio BM, Andreason P. et al.
The US Food and Drug Administration's Perspective on the New Antipsychotic Pimavanserin.

J Clin Psychiatry 2017;
78: e668-e673
DOI: 10.4088/JCP.16r11119 . (PMID: 28493654)

Download Bibliographical Data

Access:
Access: